US And Trading Neighbors Advocate Risk-Based, Science-Backed Cosmetics Regs
Executive Summary
As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.
You may also be interested in...
IFRA Chair Looks Forward To Post-COVID-19 ‘Revival Of Reason’
IFRA’s new chairman Hans Holger Gliewe says one possible positive outcome of the COVID-19 pandemic could be that consumers go on putting a premium on scientific expertise after months of reliance on health experts’ advice. The public’s changed perspective could help drive science-based regulatory decision making, a caused long championed by the fragrance and beauty product industries.
HBW Market Roundup: Expo West Postponed, FDA Needs International Cosmetics Meeting Input, More
New Hope Network postponed Natural Products Expo West trade show due to coronavirus; NPA supports Accurate Labels Act; American Health Packaging recalls OTC ranitidine; and FDA seeks input on topics for upcoming International Cooperation on Cosmetics Regulation meeting.
Ease Of Reaching Canada With Cosmetic/Drug Interface Products To Improve Under USMCA
Canada has agreed to end its practice of quarantining and retesting certain cosmetic-OTC drug products from the US, as part of a cosmetics-specific annex to the United States-Mexico-Canada Agreement. “There will be a very significant and immediate benefit to US exporters of OTC products to Canada,” a Personal Care Products Council exec said.